Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug
11 juil. 2019 08h32 HE
|
Q BioMed Inc.
NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is pleased to announce the latest updates on its non-opioid therapy for the debilitating...
Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
28 juin 2019 08h32 HE
|
Q BioMed Inc.
Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA) NEW YORK, June 28, 2019 (GLOBE...
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
22 févr. 2019 08h02 HE
|
Q BioMed Inc.
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announces multiple interviews with the company’s CEO, Denis Corin, and the Q BioMed...